BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7426460)

  • 1. In-vivo determination of lead in the skeleton after occupational exposure to lead.
    Ahlgren L; Haeger-Aronsen B; Mattsson S; Schütz A
    Br J Ind Med; 1980 May; 37(2):109-13. PubMed ID: 7426460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Severe chronic lead insult that maintains body burdens of lead related to those in the skeleton": observations by Dr. Clair Patterson conclusively demonstrated.
    Rosen JF; Pounds JG
    Environ Res; 1998 Aug; 78(2):140-51. PubMed ID: 9719618
    [No Abstract]   [Full Text] [Related]  

  • 3. Tibial lead determination by 99Tcm radiopharmaceutical x-ray fluorescence.
    Mountford PJ; Green S; Bradley DA; Lewis AD; Morgan WD
    Phys Med Biol; 1994 Apr; 39(4):773-9. PubMed ID: 15552084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of repeated occupational exposure to lead, cessation of exposure, and chelation on levels of lead in bone.
    Hu H; Pepper L; Goldman R
    Am J Ind Med; 1991; 20(6):723-35. PubMed ID: 1805610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes in bone lead concentration: implications for modelling of human bone lead metabolism.
    Brito JA; McNeill FE; Stronach I; Webber CE; Wells S; Richard N; Chettle DR
    J Environ Monit; 2001 Aug; 3(4):343-51. PubMed ID: 11523432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of in vivo X-ray fluorescence determination of skeletal lead stores.
    Sokas RK; Besarab A; McDiarmid MA; Shapiro IM; Bloch P
    Arch Environ Health; 1990; 45(5):268-72. PubMed ID: 2124094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An upgraded 109Cd K X-ray fluorescence bone Pb measurement.
    Gordon CL; Chettle DR; Webber CE
    Basic Life Sci; 1993; 60():285-8. PubMed ID: 8110129
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of lead in hydride form in bone biopsies of patients with long past lead poisoning].
    Kijewski H; Lowitz HD
    Arch Toxicol; 1982 Sep; 50(3-4):301-11. PubMed ID: 7149993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of lead poisoning.
    Wynchank S; Selby P; Ehrlich R; Todd AC
    Presse Med; 1994 Nov; 23(36):1670. PubMed ID: 7899297
    [No Abstract]   [Full Text] [Related]  

  • 10. Microprobe analysis of lead in human femur by proton induced X-ray emission (PIXE).
    Lindh U; Brune D; Nordberg G
    Sci Total Environ; 1978 Jul; 10(1):31-7. PubMed ID: 684405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray fluorescence: issues surrounding the application of a new tool for measuring burden of lead.
    Hu H; Milder FL; Burger DE
    Environ Res; 1989 Aug; 49(2):295-317. PubMed ID: 2753011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary retention of lead: an experimental study in man.
    Morrow PE; Beiter H; Amato F; Gibb FR
    Environ Res; 1980 Apr; 21(2):373-84. PubMed ID: 7408808
    [No Abstract]   [Full Text] [Related]  

  • 13. Reducing bone lead content by chelation treatment in chronic lead poisoning: an in vivo X-ray fluorescence and bone biopsy study.
    Batuman V; Wedeen RP; Bogden JD; Balestra DJ; Jones K; Schidlovsky G
    Environ Res; 1989 Feb; 48(1):70-5. PubMed ID: 2492468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The body burden of lead: comparison of mathematical models for accumulation.
    Marcus AH
    Environ Res; 1979 Jun; 19(1):79-90. PubMed ID: 116846
    [No Abstract]   [Full Text] [Related]  

  • 15. Cognitive deficits and magnetic resonance spectroscopy in adult monozygotic twins with lead poisoning.
    Weisskopf MG; Hu H; Mulkern RV; White R; Aro A; Oliveira S; Wright RO
    Environ Health Perspect; 2004 Apr; 112(5):620-5. PubMed ID: 15064171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic model to describe the disposition of lead in the rat.
    Bornemann LD; Colburn WA
    J Toxicol Environ Health; 1985; 16(3-4):631-9. PubMed ID: 4087323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo tibia lead measurements as an index of cumulative exposure in occupationally exposed subjects.
    Somervaille LJ; Chettle DR; Scott MC; Tennant DR; McKiernan MJ; Skilbeck A; Trethowan WN
    Br J Ind Med; 1988 Mar; 45(3):174-81. PubMed ID: 3348993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms.
    Hu H; Rabinowitz M; Smith D
    Environ Health Perspect; 1998 Jan; 106(1):1-8. PubMed ID: 9417769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic lead nephropathy in Queensland: alternative methods of diagnosis.
    Craswell PW; Price J; Boyle PD; Heazlewood VJ; Baddeley H; Lloyd HM; Thomas BJ; Thomas BW; Williams GM
    Aust N Z J Med; 1986 Feb; 16(1):11-9. PubMed ID: 3085647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between bone lead and hemoglobin.
    Hu H; Watanabe H; Payton M; Korrick S; Rotnitzky A
    JAMA; 1994 Nov; 272(19):1512-7. PubMed ID: 7966843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.